From LC interview this morning on the A.U.S.B.I.Z. web channel
re Pd1vax high dose cohort
" we already have the next patients lined up so it will be quick"
re what's next to develop it?? ,
" we are already planning a combination study" ... ie. Big Pharma partnership discussions are well and truely underway.
my own opinion, partnership/ licensing deal upfront and milestone fees to Imugene will easily have a face value of a billion US dollars each for both HerVaxx and Pd1 Vaxx based off existing market deals for lesser therapies.
that alone is in excess 50c per share.
sum of the parts.... add em all up.
20_30c combined value for the whole pipeline is just simply absurd .
-
- There are more pages in this discussion • 7,134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.77M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.0¢ | $461.4K | 1.681M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 134437 | 7 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |